Lu Victor M, Luther Evan M, Silva Michael A, Rangwala Shivani D, Starke Robert M, Smith Edward R, See Alfred P
Department of Neurological Surgery, University of Miami School of Medicine, 1095 NW 14th Terrace, Miami, FL, 33136, USA.
Department of Neurosurgery, University of Southern California, Los Angeles, CA, USA.
Childs Nerv Syst. 2023 Mar;39(3):733-741. doi: 10.1007/s00381-022-05687-1. Epub 2022 Sep 23.
Since the advent of endovascular treatment, the long-term prognosis of vein of Galen malformation (VOGM) has markedly improved; however, the nature of research leading to this point is unclear. The objective of this study was to define the composition of VOGM research to date, by means of a bibliometric analysis of the 100 most cited VOGM articles.
An electronic search of Elsevier's Scopus database was performed to identify the 100 most cited articles on VOGM screened against predetermined criteria. Data were then compared.
The 100 most cited VOGM articles were published between 1974 and 2017 in 38 unique journals and originated from 16 unique countries. Mean citation count and rate were 59.4 citations and 2.9 citations/year, respectively. The USA (n = 42); Hôpital de Bicêtre, France (n = 15); and Dr. Pierre Lasjaunias (n = 16) were the largest individual country, institutional, and author contributors. Compared to the older articles (published < 2000), key differences for newer articles were statistically higher citation rates (P < 0.01), more authors (P < 0.01), higher proportion of endovascular treatment descriptions (P = 0.01), and more originating from Asia Pacific (P < 0.01).
From the 100 most cited VOGM articles to date, there has been a noticeable shift from diagnosing VOGM based on the foundational work by Dr. Lasjaunias to understanding how we can model clinical outcomes now that endovascular treatment has become the standard of care. Significant shifts in prognosis are pending, and the current bibliometric data implicate we are on the precipice of more recent works making an impact in the near future.
自血管内治疗出现以来，大脑大静脉畸形（VOGM）的长期预后有了显著改善；然而，导致这一结果的研究性质尚不清楚。本研究的目的是通过对100篇被引用次数最多的VOGM文章进行文献计量分析，确定迄今为止VOGM研究的构成。
对爱思唯尔的Scopus数据库进行电子检索，以识别根据预定标准筛选出的100篇被引用次数最多的关于VOGM的文章。然后对数据进行比较。
100篇被引用次数最多的VOGM文章于1974年至2017年发表在38种不同的期刊上，来自16个不同的国家。平均被引用次数和引用率分别为59.4次引用和每年2.9次引用。美国（n = 42）；法国比塞特尔医院（n = 15）；以及皮埃尔·拉萨尼亚斯博士（n = 16）是最大的单个国家、机构和作者贡献者。与较旧的文章（发表于2000年之前）相比，较新文章的关键差异在于引用率在统计学上更高（P < 0.01）、作者更多（P < 0.01）、血管内治疗描述的比例更高（P = 0.01）以及更多来自亚太地区（P < 0.01）。
从迄今为止100篇被引用次数最多的VOGM文章来看，已经有了明显的转变，即从基于拉萨尼亚斯博士的基础工作诊断VOGM，转变为理解既然血管内治疗已成为标准治疗方法，我们如何能够对临床结果进行建模。预后的重大转变即将到来，当前的文献计量数据表明我们正处于近期作品在不久的将来产生影响的边缘。
